Filters
![]() |
|
| |||
19 of 253 products, sorted A-Z
|
1.8 ★★ ☆☆☆ (6) |
San Rafael '71 |
THC | 0.58mg/g (0.6%) | THC MINIMAL | 0mg/g (0.0%) | CBD |
eweed.pro | INDICA | csmeter © |
$4.34* ![]() |
17.2g | $0.25/g |
![]() |
Flavour / Aroma Profile | AROMA / FLVR |
|
- insufficient data - |
![]() |
Pain 2/10 |
AID** WITH |
|
+Sleep 2 |
+Arthritis 1 |
Potency | THC Minimal | |
THC | 0.58mg/g | 0.6% |
CBD | 0mg/g | 0.0% |
Plant | Indica Dominant | |
Grown In | Alberta | |
Extraction | CO2 | |
Ingredients | See Nutrition Table | |
Producer | San Rafael '71 by Aurora Cannabis | |
GTIN# |
00628582001484 (17.2g) |
Made from pure cannabinoid extract with almost no cannabis taste, a four-pack of San Rafael's tangy Blaspberry (blue raspberry) gummies are infused with an indica-dominant resin that delivers 2.5 mg of THC per piece, 10 mg total.
1971. San Rafael, California. It’s where five pals gathered every day at 4:20 to search for their holy grail – an elusive, near-mythical patch of cannabis. While this crop was never found, the story continues to inspire us today.
San Rafael ’71 is grown for discerning adults who know their stuff and care about quality cannabis. We don’t mess around when it comes to the science behind what we do, and because of that, we continue to be recognized time and time again as leaders in Canadian-grown cannabis.
About Aurora Cannabis
Aurora is shaping the future of cannabis worldwide - where innovation meets expertise to serve every need. From therapeutic relief to everyday enjoyment, our diverse portfolio of brands reflects a commitment to quality, consistency and excellence.
As Canada’s leading global medical cannabis company, we’re built on a legacy of trust and driven by a belief in the industry’s transformative potential. We grow with purpose - strategically and sustainably - leveraging our deep expertise in medical markets to unlock new opportunities.
1.0 ★ ☆☆☆☆ |
Darren | Apr-23 |
1.0 ★ ☆☆☆☆ |
Morbeus | Aug-20 |
1.0 ★ ☆☆☆☆ |
CraigO | Apr-20 |
1.0 ★ ☆☆☆☆ |
Carolyn | Aug-18 |
2.0 ★★ ☆☆☆ |
Adrian | Feb-18 |